Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies
Positive allosteric modulators (PAMs) of the cannabinoid CB1 receptor (CB<sub>1</sub>) offer potential therapeutic advantages in the treatment of neuropathic pain and addiction by avoiding the adverse effects associated with orthosteric CB<sub>1</sub> activation. Here, molecular modeling and mutagen...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-01-01
|
| Col·lecció: | Pharmaceuticals |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1424-8247/17/2/154 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|